PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

PTC Therapeutics (PTCT) Misses Q1 EPS by 49c, Revenues Miss

April 30, 2020 5:22 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q1 EPS of ($1.81), $0.49 worse than the analyst estimate of ($1.32). Revenue for the quarter came in at $68.26 million versus the consensus estimate of $81.94 million.

Financial Highlights:

Total revenues were $68.3 million for the first quarter of 2020, compared to total revenues of $53.6 million for the first quarter of 2019.Translarna net product revenues were $40.5 million for the first quarter of 2020, compared to $35.3 million for the first quarter of 2019. These results reflect an increase in net product sales in existing markets as well as continued geographic expansion into new... More